This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of various therapeutic agents, including potential drugs targeting neurological disorders and psychiatric conditions. Its unique structure, featuring a bromo-phenyl group and a trifluoro-ethylamine moiety, makes it valuable for creating compounds with specific biological activities. Additionally, it is employed in medicinal chemistry for the design of molecules that interact with receptors or enzymes in the central nervous system. Its hydrochloride form enhances stability and solubility, facilitating its use in experimental and industrial processes.